Literature DB >> 32007424

Old and new genes in primary aldosteronism.

Sheerazed Boulkroun1, Fabio Luiz Fernandes-Rosa2, Maria-Christina Zennaro3.   

Abstract

Primary aldosteronism (PA) is the most common form of secondary hypertension affecting 5%-10% of patients with arterial hypertension. In PA, high blood pressure is associated with high aldosterone and low renin levels, and often hypokalemia. In a majority of cases, autonomous aldosterone production by the adrenal gland is caused by an aldosterone producing adenoma (APA) or bilateral adrenal hyperplasia (BAH). During the last ten years, a better knowledge of the pathophysiology of PA came from the discovery of somatic and germline mutations in different genes in both sporadic and familial forms of the disease. Those genes code for ion channels and pumps, as well as proteins involved in adrenal cortex development and function. Targeted next generation sequencing following immunohistochemistry guided detection of aldosterone synthase expression allows detection of somatic mutations in up to 90% of APA, while whole exome sequencing has discovered the genetic causes of four different familial forms of PA. The identification, in BAH, of somatic mutations in aldosterone producing cell clusters open new perspectives in our understanding of the bilateral form of the disease and the development of new therapeutic approaches.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  adrenal; aldosterone producing adenoma; familial hyperaldosteronism; hypertension; ion channels; mutation

Mesh:

Substances:

Year:  2020        PMID: 32007424     DOI: 10.1016/j.beem.2020.101375

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  5 in total

Review 1.  Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.

Authors:  Lucas S Santana; Augusto G Guimaraes; Madson Q Almeida
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

Review 2.  Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Koshiro Nishimoto
Journal:  Horm Metab Res       Date:  2020-04-14       Impact factor: 2.936

Review 3.  De novo CACNA1D Ca2+ channelopathies: clinical phenotypes and molecular mechanism.

Authors:  Nadine J Ortner; Teresa Kaserer; J Nathan Copeland; Jörg Striessnig
Journal:  Pflugers Arch       Date:  2020-06-24       Impact factor: 3.657

Review 4.  Voltage-Gated Ca2+-Channel α1-Subunit de novo Missense Mutations: Gain or Loss of Function - Implications for Potential Therapies.

Authors:  Jörg Striessnig
Journal:  Front Synaptic Neurosci       Date:  2021-03-03

Review 5.  Role of glucocorticoid receptor mutations in hypertension and adrenal gland hyperplasia.

Authors:  Sophia Verouti; Edith Hummler; Paul-Emmanuel Vanderriele
Journal:  Pflugers Arch       Date:  2022-06-22       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.